Učitavanje...
Bruton tyrosine kinase inhibitors for the frontline treatment of chronic lymphocytic leukemia
Chronic lymphocytic leukemia (cll) is the most commonly diagnosed adult leukemia in Canada. Biologic heterogeneity of cll between patients results in variable disease trajectories and responses to therapy. Notably, compared with patients lacking high-risk features, those with such features—such as d...
Spremljeno u:
| Izdano u: | Curr Oncol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Multimed Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7755444/ https://ncbi.nlm.nih.gov/pubmed/33380880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.6795 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|